Global Health Updates: From Biopharmaceutical Innovations to Emerging Epidemics
Published on: June 11, 2026, 2:30 a.m. | Source: Devdiscourse
Key health updates include the FDA's approval of expanded arthritis drug uses, Organon gaining clearance from the FDA, Australia's Sigma discussing potential acquisition of Boots, and Humana divesting its stake in Gentiva. Other highlights include advancements in Ebola response, GSK's strategic acquisition, and the emergence of synthetic opioids in Europe.
